Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,64 CAD | -0,61 % | -3,53 % | -51,04 % |
26/03 | Aptose Biosciences Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023 | CI |
26/03 | Transcript : Aptose Biosciences Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 28/10/13 |
C. Payne
DFI | Director of Finance/CFO | 61 | 27/06/22 |
Chief Tech/Sci/R&D Officer | - | 01/11/19 | |
Rafael Bejar
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/01/20 |
Investor Relations Contact | - | - | |
Marc Wiles
LAW | General Counsel | - | - |
Brooks Ensign
AUD | Comptroller/Controller/Auditor | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 19/09/07 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 13/09/22 |
Mark Vincent
BRD | Director/Board Member | 71 | 19/09/07 |
Director/Board Member | 74 | 15/12/14 | |
William Rice
CEO | Chief Executive Officer | 65 | 28/10/13 |
Warren Whitehead
BRD | Director/Board Member | 71 | 07/04/11 |
Carol Ashe
BRD | Director/Board Member | 66 | 15/08/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 16 252 114 | 13 153 575 ( 80,93 %) | 0 | 80,93 % |
Información de la empresa
Aptose Biosciences, Inc.
251 Consumers Road Suite 1105
M2J 4R3, Toronto
+647 479 9828
http://www.aptose.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-51,04 % | 18,84 M | |
+25,69 % | 47,9 mil M | |
+46,90 % | 41,42 mil M | |
-3,46 % | 40,7 mil M | |
-6,20 % | 28,92 mil M | |
+9,17 % | 25,55 mil M | |
-20,42 % | 19,27 mil M | |
+0,17 % | 12,15 mil M | |
+28,07 % | 12,14 mil M | |
-1,24 % | 11,99 mil M |
- Bolsa de valores
- Acciones
- Acción APS
- Empresa Aptose Biosciences Inc.